Highlights Sun Pharma, Dr Reddy’s Labs and Cipla see upgrades in earnings estimates after September quarter results All three companies have clocked healthy growth in US sales last quarter The companies’ efforts to mitigate the impact of US generic price erosion are beginning to bear fruit Large pharmaceutical companies that sell finished dosage drugs in India and abroad are finally getting a grip on growth. After years of unexciting results Sun Pharmaceutical Industries, Dr Reddy’s Laboratories and Cipla have seen upgrades in earnings...
Moneycontrol Pro Panorama | Will the MPC signal a pause?
Feb 6, 2023 / 03:05 PM IST
In today’s edition of Moneycontrol Pro Panorama: Market outlook for automakers gets a lift, will GST Council come up with wider ...Read Now
To read the full story, Subscribe to Moneycontrol PRO
Access the exclusive stories, weekly investment ideas and daily technical calls in an Ad free experience
Already a member? Sign in
Limited Period offer on Moneycontrol PRO. Subscribe to PRO and get up to
Ad free experience
Experience a non-intrusive navigation and faster response in the ad free mode
Access to 230+ exclusive stories per month from our editorial and Experts
Have a Global edge with access to content from world renowned experts and journalist
Access to 40+ weekly investment ideas including 4 daily technical calls
Exclusive access to live webinars from market experts on trading and investment strategies
Daily and weekly insights bundled and sent to your inbox to keep you ahead in the race.
Get upto 50% discount on limited period offers